Another milestone reached: Research results from the Bliss-52 study has been released. Bliss-52 is one of the two crucial trials conducted to evaluate the efficacy of Benlysta—the first potential lupus treatment in over 50 years that’s pending FDA approval next month. http://bit.ly/eCB49M
No comments:
Post a Comment